The has selected Susan Desmond-Hellmann, M.D., M.P.H., currently chancellor of the , to be its next chief executive officer.
An oncologist by training, Desmond-Hellmann is a recognized leader on issues of higher education, public health, drug development, regulatory innovation, and health policy. Prior to becoming the first woman to serve as UCSF chancellor in 2009, she was president of product development at , where she led the development and introduction of two of the first gene-targeted therapies for cancer. Desmond-Hellmann will join the foundation in her new role on May 1, 2014, succeeding Jeff Raikes, who announced in September his intention to retire after serving as CEO of the foundation for five years.
"We chose Sue because of her scientific knowledge and deep technical expertise on the foundation’s issues, as well as the organizational and leadership skills required to lead a large, growing, and dynamic global organization," said Gates Foundation co-chair Melinda Gates. "Sue shares our commitment and passion to create a more equitable world."
"Sue's background in public health policy, research and development, and higher education, make her an exceptional fit for this role," said foundation co-chair Bill Gates. "She impressed us as an innovator and an outstanding leader and manager."